Objective-Heat shock protein 70s (Hsp70s) are molecular chaperones that protect cells from damage in response to various stress stimuli. However, the functions and mechanisms in endothelial cells (ECs) have not been examined. Herein, we investigate the role of Hsp70s, including heat shock cognate protein 70 (Hsc70), which is constitutively expressed in nonstressed cells (ie, ECs).
T he heat shock protein 70 (Hsp70) family plays important roles in normal cellular function and homeostasis. Hsp70s function as molecular chaperones, assisting in protein synthesis, folding, assembly, trafficking between cellular compartments, and degradation. 1, 2 They are expressed constitutively and induced in response to various types of stress, including heat shock, ischemia, oxidative stress, glucose deprivation, and exposure to toxins. 3 Hsp72, a member of the Hsp70 family, protects cells, tissues, and organs from various harmful conditions in blood vessels. Previous work 4, 5 has shown that an increase in levels of a particular Hsp72, induced by heat stress, is associated with the protection of ventricular and endothelial function after ischemia-reperfusion injury. Several studies 6 -9 have been reported that upregulation of Hsp72 in cells by gene transfer greatly increases the resistance of myocardial cells in vitro and in transgenic mice. On the other hand, deletion of Hsp72 leads to dysfunctional cardiomyocytes and impaired stress response of Hsp72-knockout hearts against ischemia/ reperfusion. 10 Thus, Hsp72 may be expected to play a protective role by reducing the risk of myocardial cell injury and exerting its beneficial effects on endothelial function. However, little is known about the functional role of Hsp70 family members in response to ischemic injury.
The human Hsp70 family, which is the largest and most conserved Hsp family, contains at least eight homologous chaperone proteins. This family includes the Hsp72-inducible protein and constitutively expresses the heat shock cognate protein 70 (Hsc70) isoform, both of which are localized to the cytoplasm. Two members of the Hsp70 family, Hsc70 and Hsp72, have a high degree of sequence homology (86% sequence identity), and both proteins copurify with one another. Hsc70 is abundantly and ubiquitously expressed in all cells, whereas Hsp72 is expressed only at low levels in most unstressed healthy cells and tissues. However, its expression is rapidly induced by a variety of physical and chemical stresses; therefore, it is often called the major stress-inducible Hsp70. It is suggested that Hsp72 and Hsc70 can substitute for each other in healthy cells, whereas Hsp72 expression is essential for certain cells to respond to some cytotoxic factors. There are several chaperone mechanisms based on inducible Hsp72 and constitutive Hsc70. Although both bind to misfolded proteins, newly synthesized polypeptides (ie, Hsp72 and Hsc70) function in the cytosol, suggesting that they display specificity for their client proteins or, alternatively, serve particular chaperone-independent functions. 11 Previous studies mainly analyzed Hsp72 under vari-ous stress conditions; however, there is little research on Hsc70 in the cardiovascular system.
In the present study, we investigated whether Hsp70s modulate the angiogenic process. Recently, it has been reported that RNAi-mediated knockdown of human Hsc 70 A12B, a member of the Hsp70 family, disrupted normal zebra fish blood vessel development and inhibited in vitro angiogenesis and migration in human umbilical vein endothelial cells (HUVECs). 12 Additional Hsp70 family members could modulate these important functions as well. However, the role and mechanism of Hsp70s, including Hsc70, in endothelial cells (ECs) were not examined. We examined the ability of Hsp70s to induce EC migration, the formation of capillarylike structures, and endothelial nitric oxide synthase (eNOS) activation. We also tested whether Hsp70s are required for angiogenesis in a hind limb ischemia model. Our observations indicate that Hsp70s are essential for Akt activation and the maintenance of endothelial function. Furthermore, the knockdown of Hsc70 revealed the reduction of phosphatidylinositol 3-kinase (PI3K) p110 protein in HUVECs. Hsc70 may play a critical role in the regulation of EC function through the phosphorylation of Akt.
Methods
Additional methods and details are presented in the Data Supplement available online at http://atvb.ahajournals.org.
Materials and Cell Culture
Vascular endothelial growth factor (VEGF) 165 and N-formyl-3,4methylenedioxy-benzylidene-␥-butyrolactam (a KNK437, Hsp70 inhibitor) were obtained from Calbiochem (La Jolla, Calif). Endothelial cell growth medium (EGM)2 and endothelial cell basal medium (EBM)2 culture media and HUVECs (passage Յ5) were obtained from Lonza (Walkersville, Md). HUVECs were grown at 37°C in a humidified atmosphere of 5% carbon dioxide in EGM2 medium.
The supplemental data also provide information regarding immunoblotting, migration assay, in vitro angiogenesis, and real-time reverse transcription-polymerase chain reaction (RT-PCR) analysis.
In Vivo Models of Angiogenesis
All procedures were in accordance with institutional guidelines for animal research. Male C57BL/6J mice (aged 8 weeks) were purchased from Japan Clea (Tokyo, Japan). Unilateral hind limb ischemia was induced by resecting the left femoral arteries and veins, as described previously. Mice were injected intraperitoneally with 50 g/g of KNK437 or dimethyl sulfoxide as control daily from the day unilateral hind limb ischemia was induced to day 5. Hind limb blood flow by laser Doppler blood flow (LDBF) analyzer and capillary density with anti-CD31 antibody (BD Biosciences Pharmingen, San Jose, Calif) were measured on day 5, as described previously. 13 
RNA Interference
All small interfering RNAs (siRNAs) against human Hsc70 A8 and Silencer negative control number 1 siRNA were obtained from Ambion, Austin, Tex. Lipofectamin RNAiMAX (Invitrogen) was used to transfect siRNAs into the HUVECs (final concentration, 10 nmol/L), as suggested in the manual. The sense sequences of the siRNAs are as follows: (1) 5Ј-CCUAAAUUCGUAGCAAAUUtt-3Ј, (2) 5Ј-GGAGGUGUCUUCUAUGGUUtt-3Ј, (3) 5Ј-UGAUGCUG-UUGUCCAGUCUGAtt-3Ј. After 48 hours of reverse transfection, quantitative RT-PCR and immunoblotting were performed to examine the knockdown of targeted molecules.
Statistical Analysis
All data are presented as meanϮSD. Comparisons among groups were made by one-way analysis of variance. For differences between 2 groups, the t test was used when appropriate. Differences were considered statistically significant at PϽ0.05.
Results

Blockade of Hsp70 Suppresses VEGF-Induced Migration and Tube Formation
In this study, we investigated the effects of a Hsp inhibitor, N-formyl-3,4-methylenedioxy-benzylidene-␥-butyrolactam (KNK437), on ECs. KNK437 was reported to inhibit the acquisition of thermotolerance and the inhibition of various Hsps, including Hsp110, Hsp72, and Hsp40, in human colon cancer cells. 14 To evaluate the function of Hsp70s in ECs, we first studied the effects of an HSP inhibitor, KNK437, on angiogenesis. Angiogenesis incorporates cell survival, migration, intercellular connections with other ECs, and lumen formation. In vitro angiogenesis was assessed by tube formation assay using Matrigel. KNK437, 100 mol/L, significantly inhibited VEGF, 10 ng/mL, induced tube formation ( Figure 1A) . Because angiogenesis involves cell migration, we investigated the role of Hsp70s in VEGF-promoted migration of HUVECs using a modified Boyden chamber method. KNK437 treatment suppressed VEGF-induced cell migration ( Figure 1B ). Next, we measured the phosphorylation of eNOS because eNOS activation is important in endothelial function. VEGF provoked phosphorylation of eNOS at serine (Ser) 1177, which could be blocked by KNK437 pretreatment for 1 hour ( Figure 1C and Supplemental Figure I ). Taken together, these results suggest that blockade of Hsp70s suppressed angiogenesis, indicating that endogenous Hsp70s are important for angiogenic activity of ECs.
LDBF Analysis and Tissue Capillary Density
To further substantiate a role for Hsp70s in angiogenic activity, we used an ischemic hind limb model of in vivo angiogenesis. Immediately after the left femoral artery and vein were resected, the ratio of ischemic (left) to nonischemic (right) hind limb LDBF (the LDBF ratio) decreased from 1.01Ϯ0.02 to 0.06Ϯ0.02 in vehicle mice and from 1.01Ϯ0.02 to 0.07Ϯ0.04 in KNK437treated mice, indicating a similar level of ischemia. Figure 2A shows representative LDBF images of hind limb blood flow on day 5. A serial LDBF examination showed that hind limb blood flow recovered in vehicle mice after the induction of ischemia, but treatment with KNK437 blocked this recovery: the LDBF ratio in KNK437-treated mice was low at 5 days after the induction of ischemia (55% decrease, PϽ0.05; Figure 2A ). To investigate microcirculation, we measured capillary density in histological sections harvested from the ischemic tissues by anti-CD31 antibody. KNK437 significantly reduced capillary density on postoperative day 5 compared with vehicle mice ( Figure 2B ).
Effects of KNK437 on Akt Phosphorylation
Akt phosphorylation is one of the key steps in transducing angiogenic signals, including those initiated by VEGF, 15 an important regulator of various cellular processes (ie, metabolism, cell survival, migration, and nitric oxide release). 16, 17 VEGFstimulated activation of the PI3K/Akt pathway plays an essential role in the regulation of eNOS activity. To determine the role of Hsp70s in VEGF-provoked Akt phosphorylation, HUVECs were pretreated with KNK437, 100 mol/L, or vehicle for 1 hour, and then stimulated with or without VEGF for 30 minutes. KNK437 inhibited VEGF-induced Akt-Ser473 phosphorylation, whereas total Akt protein expression barely changed ( Figure  3A) . These results indicate that Hsp70s mediate VEGF-induced Akt phosphorylation in HUVECs.
Next, to determine whether Hsp70s are directly involved in Akt activity in vivo, we examined the effect of KNK437 on the phosphorylation of Akt in ischemic mouse tissues. Hind limb ischemia induced Akt phosphorylation, which peaked at 60 minutes (data not shown). Pretreatment of KNK437 completely blocked this peaked Akt phosphorylation ( Figure  3B ). Treatment with KNK437 did not affect Akt activity in nonischemic muscles. These data demonstrate that pharmacological inhibition of the function of Hsp70s attenuated the activity of Akt, leading to suppression of angiogenesis.
Interference With Hsc70 Induces Endothelial Dysfunction
KNK437 was reported to broadly affect Hsp family members. 14 The induction of heat-inducible Hsp70s was inhibited at the messenger RNA (mRNA) level by treatment with KNK437, although the precise mechanism of KNK437-induced suppression of Hsp70 transcription has not been elucidated. Therefore, we analyzed mRNA expression of the Hsp family in KNK437treated HUVECs by quantitative RT-PCR under non-heatstressed conditions. KNK437 reduced the expression of Hsps to less than the basal level under nonstressed conditions. Treatment with KNK437 for 6 hours (the time point of migration and in vitro angiogenesis assay) significantly reduced the expression of Hsc70, Hsp72, Hsp40, and Hsp90␣, but not of Hsp90␤ or Hsp110. A 1.5-hour treatment (time point of immunoblotting) significantly reduced the expression of Hsp72, Hsp40, and Hsc70, but not of Hsp90␣ (Supplemental Figure II) . Taken together, the data indicate that KNK437 suppressed Hsp72, Hsp40, and Hsc70 under a nonstress condition. Because KNK437 treatment decreased mRNA expression of Hsc70, a stress-noninducible Hsp, we next focused on the role of Hsc70 in endothelial function.
To determine whether Hsc70 is also required to regulate EC function, we used siRNA to block Hsc70 transcription. Three siRNAs (siRNA1, siRNA2, and siRNA3) and a negative control were tested against endogenous Hsc70 in HUVECs. These siRNA constructs were specific for Hsc70 and did not crossreact with Hsp72. All constructs resulted in moderate knockdown of Hsc70 expression by reducing mRNA expression (Supplemental Figure III) . Because Hsc70-reduced cells detached from the substratum after 48 hours of transfection, we investigated cell number ( Figure 4A ). Hsc70-knockdown cells reduced their number to 60% compared with that of the control cells. Nevertheless, there were no significant differences in the level of cleaved caspase 3 (Supplemental Figure IV) . Next, to investigate the specificity of Hsc70 knockdown, we determined the level of expression of Hsp family genes, which is affected by Figure V) . Therefore, it is believed that the influence of siRNA is specific for Hsc70 but not Hsp72. HUVECs were then transfected with Hsc70 siRNA (siRNA1) or the negative control, and angiogenesis was evaluated by tube formation assay after 48 hours. Hsc70 knockdown significantly blocked the normal formation of tubelike structures ( Figure 4B ). A similar result was obtained with the siRNA2 construct. siRNA1 treatment significantly inhibited VEGF-induced migration ( Figure 4C ). Thus, silencing of Hsc70 blocked endothelial migration and tube formation, indicating that endogenous Hsc70 is essential for angiogenic activity in ECs.
Hsc70 Is Essential for Akt Phosphorylation in ECs
Furthermore, we tested the effects of Hsc70 siRNA on VEGFinduced Akt phosphorylation. At 48 hours after transfection, cells were starved and treated with VEGF for 30 minutes. HUVECs transfected with siRNA showed diminished phosphorylation of Akt (Ser473) in the presence of VEGF ( Figure 5 and Supplemental Figure VI) , but total levels of Akt1 protein did not change. These results are in good agreement with the data shown Figure 3A .
Depletion of Hsc70 Reduces PI3K Expression
Finally, to clarify how Hsc70 affected Akt activation, we evaluated the activation of molecules that play a role in its activation. As shown in Supplemental Figure VII , the depletion of Hsc70 prevented VEGF-induced phosphorylation of threonine 308 and Ser473 on Akt. However, knockdown of Hsc70 did not affect the expression of mammalian targets of rapamycin and rictor, which phosphorylate Akt at Ser473. In contrast, depletion of Hsc70 enhanced the expression of 3-phosphoinositidedependent kinase 1 (PDK1), which phosphorylates threonine 308. On the other hand, Hsc70 siRNA downregulated produc-tion of PI3K p110 subunits to less than 40%, and a modest decrease in p85 was observed ( Figure 6A) . A similar result was obtained with KNK437 treatment, which reduced the production of the PI3K p110 subunits ( Figure 6B ). As shown in Supplemental Figure II , a significant decrease in the amount of p110 protein and mRNA was not observed under an Hsp40 or an Hsp72 knockdown condition, although both of them were inhibited by KNK437 (Supplemental Figure VIII) . The knockdown of Hsp72 blocked VEGF-induced phosphorylation of Akt, whereas PI3K p110 production was not changed (Supplemental Figure IXA) . Likewise, geldanamycin, an Hsp90 inhibitor, failed to decrease the p110 production by VEGF (Supplemental Figure  IXB) . Because knockdown of Hsc70 increased the expression of Hsp72, Hsp40, Hsp90␣, Hsp90␤, and Hsp110 (Supplemental Figure V) , we assessed the effects of overexpression of these molecules. Overexpression of each of the previously mentioned Hsps did not alter the level of p110 protein (Supplemental Figure  X) . Because the PI3K p110 antibody used recognizes all subclasses of p110, we determined whether isoform variants of p110 mRNA were downregulated in response to Hsc70 siRNA treatment. Quantitative RT-PCR revealed that the expression of p110␣ and p110␥ was significantly inhibited to 80% and 50%, respectively, by Hsc70 siRNA (Figure 6C) . These results suggest that Hsc70 has a critical role in the transcription or stability of PI3K mRNA.
Discussion
Herein, we provide evidence showing that Hsp70s, especially Hsc70, are essential for EC function, including angiogenesis, via regulation of the Akt pathway. First, we demonstrated that pharmacological inhibition of Hsp70s attenuates Akt activity, leading to suppression of EC migration and capillary-like tube formation. Moreover, the inhibition of Hsp70s abrogated blood vessel recruitment in a mouse hind limb model of vascular insufficiency, as evaluated by laser Doppler flow and capillary density analysis. These observations show that Hsp70s are essential for angiogenesis via activation of PI3K-Akt signaling. KNK437 is not specific for Hsc70, but it inhibited the expression level of Hsc70 at each time point of the assay (1.5 and 6 hours). Therefore, we presumed that these results were caused by downregulation of Hsc70. Hsc70 knockdown significantly suppressed EC migration and tube formation in vitro. Furthermore, the depression of Hsc70 decreased the activation of Akt and its downstream effector molecules, including eNOS. Because activation of Akt is a trigger and is essential for endothelial function and postnatal angiogenesis, we further elucidated the mechanism of Akt activation in Hsc70-silenced HUVECs. The data presented herein suggest that the molecular mechanism is due to inhibition of PI3K protein production by Hsc70 knockdown. The attenuation of Hsc70 could abrogate endothelial functions by blocking PI3K/Akt activation. Thus, the Akt pathway might regulate angiogenic responses by several distinct and possibly counterbalancing mechanisms.
Hsp70s participate in cellular stress responses by binding and refolding damaged proteins or removing consistently misfolded proteins through the ubiquitin-proteasome system or autophagy. In addition to their chaperone functions, the Hsp70s have also been reported to act as signaling molecules 1819 and regulators in cellular processes such as apoptosis. 20, 21 Hsp90␤, which is constitutively expressed in vascular ECs, also functions as a scaffold protein for eNOS and Akt, 22, 23 and coordinates the trafficking and regulation of diverse signaling proteins. Recently, it has been shown that Hsp72 is identified as a rictorbinding protein and a component of the mammalian target of rapamycin complex 2. 24 Activation of mammalian target of rapamycin complex 2, which consists of rictor, leads to the phosphorylation of Akt at Ser473, resulting in full activation of Akt. 25 Thus, the observation that Hsp70s regulate kinase function is not unique. Therefore, we considered the possibility of Hsc70 functioning as a scaffold protein for mammalian target of rapamycin complex 2 and Akt. However, an immunoprecipitation analysis revealed that Hsc70 reduction did not change the amount of Akt bound to rictor (data not shown). Although it is also reported that Akt Ser473 and threonine 308 are phosphorylated by PDK1, 26, 27 we did not detect PDK1 binding or changes in PDK1 phosphorylation (data not shown). Moreover, the inhibition of Hsc70 gene expression did not reduce the expression of mammalian targets of rapamycin, rictor, or PDK1 (Supplemental Figure VII) . Finally, we evaluated the expression of PI3K, which functions upstream of Akt in the signaling cascade. The data revealed that Hsc70 siRNA significantly reduced p110 protein production ( Figure 6 ). Furthermore, we investigated the relative abundance of mRNAs encoding p110␣, which form heterodimers with p85; and p110␥, which do not form heterodimers with p85. The data indicated that knockdown of Hsc70 gene expression inhibited the steady-state levels of p110␥ mRNA to a greater degree than p110␣ mRNA. This result is consistent with the knowledge that PI3K p110␥ participates in control of Akt phosphorylation. 28 Recently, Madeddu et al 29 reported that PI3K p110␥ modulates angiogenesis, arteriogenesis, and vasculogenesis. Hsc70 may regulate the expression of PI3K by being involved with the control of stabilization and the degradation of PI3K. There is report that Hsc70 plays an interesting role in the cytokine-mediated posttranscriptional regulation of the proapoptotic Bcl-2 (B-cell lymphoma/ leukemia-2) family member, Bim (B-cell lymphoma 2 interacting mediator of cell death), in human blood cells. 30 Hsc70 may be recognized as an active component constitutively involved in many cellular processes, including stabilization and degradation of mRNA.
Hsc70 is considered an essential housekeeping gene, and Hsc70-knockout mice are embryonically lethal as a result of the essential role of Hsc70 in cell survival. 31 Transfection with Hsc70 siRNA results in massive cell death in various cell types. 32, 33 As a consequence of this inhibition, we observed a decrease in cell number. Akt also contributes to cell survival, 34 -36 and Akt blockade by Hsc70 may trigger cell death. Indeed, depression of Hsc70 downregulated Akt-driven phosphorylation of eNOS (data not shown). These data clearly implicate Hsc70 as a critical facilitator of Akt-mediated cell survival in response to VEGF. In the present study, knockdown of Hsc70 for 48 hours caused cell death of less than 40% in ECs ( Figure 4A ). However, the inhibition of angiogenesis by blocking Hsc70 did not result in cell death because we did not detect any remarkable cell death during the tube formation and migration assay ( Figure 4B and C, control versus Hsc70 siRNA treatment).
PI3K/Akt signaling regulates multiple steps in angiogenesis, including EC survival, migration, and capillary-like structure formation. Furthermore, this signaling pathway also regulates cardiovascular homeostasis and vessel integrity at least in part by controlling NO synthesis. Several groups 16, 29, 37 have shown that inhibition of PI3K or its downstream target Akt blocked VEGF-stimulated migration in ECs. Hsc70 is constitutively expressed in ECs and may promote endothelial health and may, therefore, be important in treating disorders that result from endothelial dysfunction. 38 Thus, one potential mechanism by which knockdown of Hsc70 induces endothelial dysfunction is regulation of the PI3K/Akt pathway. This study also provides data supporting a role for Hsp70s in regulating ischemic and postnatal angiogenesis in vivo. The loss of eNOS, 39, 40 Akt, 41 or PI3K 29 in response to tissue injury or exogenous angiogenic factors results in severe peripheral vascular disease. Treatment of KNK437 attenuated postischemic mechanical and endothelial functions, similar to the results obtained with Akt knockout mice. 41 These data indicate that there are distinct regulatory mechanisms that involve the Hsp70s, including Hsc70, in blood vessel recruitment during normal tissue development and in response to pathological stimuli, such as ischemic stress. Collectively, these findings suggest that Hsc70 plays a fundamental role in maintaining homeostasis in ECs. Herein, it was found that knockdown of Hsc70 downregulates PI3K p110 expression, leading to Akt inactivation. This is consistent with the hypothesis that Hsc70 downregulation promotes endothelial dysfunction via inactivation of the PI3K/Akt pathway. Therefore, we hypothesize that Akt activation by Hsc70 is one of many regulatory mechanisms needed to maintain endothelial homeostasis. However, further study would be required to clarify the mechanistic details.
In conclusion, the present study demonstrates that Hsc70 is essential for multiple EC functions via the PI3K/Akt pathway. Hsc70 may promote endothelial health and may, therefore, be important in the treatment of disorders in which there is evidence of endothelial dysfunction. Angiogenesis has been implicated in the pathophysiology of a number of diseases, and regulation of vasculogenesis could be an important therapeutic strategy for those diseases. Thus, further elucidation of the mechanism of Akt activation via Hsc70 may reveal important information on which the development of novel therapeutic interventions and new therapeutic medicines can be based.
